Oncternal Therapeutics (ONCT) Q4 2023 Earnings

7MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-3.11
-2.12
-1.13
-0.14

Details

Expected EPS
-3.07
Actual EPS
-3.11
Surprise EPS
-0.04
Surprise Percent
+1.3%

Description

Oncternal Therapeutics (ONCT) has reported earnings of -3.11 per share for Q4 2023.

0 Comments

Share your thoughts